To assess the middle-term outcome of iguratimod (IGU) in rheumatoid arthritis (RA) patients. Sixty-nine RA patients (14 males and 55 females, mean age of 64.0 years) receiving IGU-containing therapies were enrolled. We divided these patients into three groups based on the treatment at the baseline: an IGU group, a methotrexate (MTX) plus IGU group, and a biologics plus IGU group. The baseline characteristics and clinical course were evaluated over three years. Predictive factors associated with the achievement of low disease activity (LDA) were statistically analyzed. The survival rate of IGU therapy at 3 years was 40.6%. The disease activity was significantly decreased in the IGU group and MTX plus IGU group compared with the baseline. Furthermore, 38 patients (55.1%) were in remission or had LDA at 3 years. The patient gender, use of prednisolone (PSL) and DAS28-CRP at baseline were the factors associated with the achievement of remission or LDA at three years. IGU was effective without MTX or bDMARDs as well as in combination with MTX. A female gender, no use of PSL and a low DAS28-CRP at the initiation of IGU were associated with clinical remission or LDA achievement at three years.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/14397595.2018.1510879 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Incarceration of the gravid uterus: Ultrasound diagnosis and pregnancy outcomes.
J Clin Ultrasound
September 2024
Department of Ultrasound, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, China.
Article Synopsis
- This research investigates the ultrasound characteristics and outcomes of incarceration of the gravid uterus (IGU) in pregnant women to assist in medical management.
- A study at Hunan Provincial Maternal and Child Health Care Hospital analyzed 13 diagnosed IGU cases out of 140,162 deliveries, revealing prior abdominal surgery as the main risk factor and dysuria as a common symptom.
- The findings suggest that, while IGU is rare and often has a good prognosis, regular monitoring may be sufficient if there are no severe symptoms, with ultrasound being critical for diagnosis.
The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis.
Chin Med J (Engl)
July 2024
Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai 200001, China.
Article Synopsis
- Rheumatoid arthritis (RA) is a chronic autoimmune disease leading to joint inflammation and destruction, and iguratimod (IGU) is a new treatment option showing promise in China and Japan.
- A clinical trial with 911 patients tested the efficacy of IGU alone, methotrexate (MTX) alone, and a combination of both over 52 weeks, assessing various disease activity indices and bone destruction.
- Results indicated that IGU monotherapy achieved a similar effectiveness to MTX monotherapy, with a higher percentage of patients demonstrating improved symptoms at week 52, confirming IGU's potential as an effective alternative treatment for active RA.
Lack of association of impaired upper airway sensation with the presence or absence of obstructive sleep apnoea or chronic rhinosinusitis in World Trade Center responders.
Occup Environ Med
July 2024
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
Objective: Examine sensory function of the upper airway in four groups of subjects recruited from the World Trade Centre General Responder Cohort (WTCGRC), with/without obstructive sleep apnoea (OSA), and with/without chronic rhinosinusitis (CRS).
Methods: Upper airway sensory function was determined using 2-point discrimination (2-PD) and vibration threshold (VT) in 163 WTCGRC subjects with both OSA and CRS (cases), OSA or CRS alone and without OSA or CRS (controls). Presence of OSA was determined from clinical sleep studies or home sleep testing.
Taxonomic revision of the jumping spider genus Tullgrenella Mello-Leito, 1941 (Araneae: Salticidae: Freyina).
Zootaxa
February 2024
Departamento de Morfologia e Fisiologia Animal; Universidade Estadual Paulista Jlio de Mesquita Filho (UNESP); Via de Acesso Prof. Paulo Donato Castellane; km 05; 14884900; Jaboticabal; SP; Brazil.
This paper presents a taxonomic revision of the genus Tullgrenella Mello-Leito, 1941. Four new species are described: Tullgrenella aisenbergae Marta, sp. nov.
View Article and Find Full Text PDFEfficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials.
Front Pharmacol
December 2023
Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Graduate School of Peking Union Medical College, Nanjing, China.
To evaluate efficacy and safety of iguratimod (IGU) in the treatment of rheumatic and autoimmune diseases. Databases such as Pubmed, Embase, Sinomed were searched (as of July 2022) to collect randomized controlled trials (RCTs) of IGU in the treatment of rheumatic and autoimmune diseases. Two researchers independently screened the literature, extracted data, assessed the risk of bias of the included literature, and performed meta-analysis using RevMan 5.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!